Article Information
History
- January 21, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Kuppusamy Balamurugan1,*,
- Saadiya Sehareen1,
- Shikha Sharan1,
- Savitri Krishnamurthy2,
- Wei Tang3,
- Lois McKennett4,
- Veena Padmanaban5,6,
- Kelli Czarra4,
- Andrew J. Ewald5,
- Naoto T. Ueno2,
- Stefan Ambs3,
- Dipak K. Poria1 and
- Esta Sterneck1,*
- 1Laboratory of Cell and Developmental Signaling, Center for Cancer Research (CCR), National Cancer Institute (NCI), Frederick, MD, USA
- 2Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 3Laboratory of Human Carcinogenesis, CCR, NCI, Bethesda, MD, USA
- 4Laboratory Animal Sciences Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA
- 5Departments of Cell Biology and Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 6Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA
- ↵*Corresponding authors: Esta Sterneck, sternecg{at}mail.nih.gov, tel.+1-301-846-1471, Kuppusamy Balamurugan, kuppusamyb{at}mail.nih.gov, tel.+1-301-846-5257, National Cancer Institute, 1050 Boyles Street, Frederick, MD 21702-120, U.S.A.